Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep;20(9):2159-2160.
doi: 10.1111/jth.15791.

"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": Comment from Wada et al

Affiliations
Comment

"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": Comment from Wada et al

Hideo Wada et al. J Thromb Haemost. 2022 Sep.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Plasma levels of sCLEC2 and sCLEC‐2/D‐dimer ratio in patients with COVID‐19 infection and those with other infections. #p < .001, #p < .01 and #p < .05; p < .001, p < .01, and p < .05 in comparison to unidentified clinical syndrome, respectively.

Comment in

Comment on

  • Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19.
    Maugeri N, De Lorenzo R, Clementi N, Antonia Diotti R, Criscuolo E, Godino C, Tresoldi C, Angels For Covid-BioB Study Group B, Bonini C, Clementi M, Mancini N, Ciceri F, Rovere-Querini P, Manfredi AA. Maugeri N, et al. J Thromb Haemost. 2022 Feb;20(2):434-448. doi: 10.1111/jth.15575. Epub 2021 Nov 16. J Thromb Haemost. 2022. PMID: 34710269 Free PMC article.

Similar articles

Cited by

References

    1. Maugeri N., De Lorenzo R., Clementi N., et al. Unconventional CD147‐dependent platelet activation elicited by SARS‐CoV‐2 in COVID‐19. J Thromb Haemost. 2022;20(2):434–448. - PMC - PubMed
    1. Evans J.P., Liu S.L. Role of host factors in SARS‐CoV‐2 entry. J Biol Chem. 2021;297 - PMC - PubMed
    1. Berlin D.A., Gulick R.M., Martinez F.J. Severe COVID‐19. N Engl J Med. 2020;383:2451–2460. - PubMed
    1. Suzuki‐Inoue K., Fuller G.L., Garcia A., et al. A novel Syk‐dependent mechanism of platelet activation by the C‐type lectin receptor sCLEC‐2. Blood. 2006;107:542–549. - PubMed
    1. Yamashita Y., Suzuki K., Mastumoto T., et al. Elevated plasma levels of soluble C‐type lectin‐like receptor 2 (CLEC2) in patients with thrombotic microangiopathy. Thromb Res. 2019;178:54–58. - PubMed